perfosfamide has been researched along with Glioblastoma with Sarcomatous Component in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CS; Schwartz, PS; Waxman, DJ | 1 |
| Brem, H; Buahin, KG | 1 |
2 other study(ies) available for perfosfamide and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Enhanced bystander cytotoxicity of P450 gene-directed enzyme prodrug therapy by expression of the antiapoptotic factor p35.
Topics: Animals; Apoptosis; Biotransformation; Caspase Inhibitors; Caspases; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzyme Activation; Genetic Therapy; Gliosarcoma; Glutathione; Humans; Inhibitor of Apoptosis Proteins; NADPH-Ferrihemoprotein Reductase; Prodrugs; Rats; Tumor Cells, Cultured; Viral Proteins | 2002 |
Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Transplantation; Cyclophosphamide; Delayed-Action Preparations; Gliosarcoma; Injections; Male; Neoplasm Transplantation; Polymers; Rats; Rats, Inbred F344 | 1995 |